PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis. (Q52956251)

30 June 2019

title

PKC-β activation inhibits IL-18-binding protein causing endothelial dysfunction and diabetic atherosclerosis. (English)

1 reference

30 June 2019

1 reference

6

Marie-Odile Guimond

1 reference

30 June 2019

Marie-Claude Durpès

1

1 reference

30 June 2019

Catherine Morin

2

1 reference

30 June 2019

Judith Paquin-Veillet

3

1 reference

30 June 2019

Raphaël Beland

4

1 reference

30 June 2019

Martin Paré

5

1 reference

30 June 2019

Mark Rekhter

7

1 reference

30 June 2019

George L King

8

1 reference

30 June 2019

Pedro Geraldes

9

1 reference

30 June 2019

publication date

24 March 2015

1 reference

30 June 2019

published in

Cardiovascular Research

1 reference

30 June 2019

volume

106

1 reference

30 June 2019

page(s)

303-313

1 reference

30 June 2019

issue

2

1 reference

30 June 2019

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6279179/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Emerging and diverse roles of protein kinase C in immune cell signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Critical role of protein kinase C epsilon for lipopolysaccharide-induced IL-12 synthesis in monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18 and IL-18 binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Chronic inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Up-regulation of IL-18BP, but not IL-18 mRNA in rat liver by LPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Circulating IL-18 and the risk of type 2 diabetes in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Cytokine regulation of cellular adhesion molecule expression in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

The effect of ruboxistaurin on nephropathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Induction of vascular insulin resistance and endothelin-1 expression and acceleration of atherosclerosis by the overexpression of protein kinase C-β isoform in the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Adipose tissue, inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

High glucose driven expression of pro-inflammatory cytokine and chemokine genes in lymphocytes: molecular mechanisms of IL-17 family gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: Results from the ESTHER study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Atherosclerotic Lesion Development and Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV107

Correlation between the levels of circulating adhesion molecules and atherosclerosis in hypertensive type-2 diabetic patients

21 January 2018

1 reference

12 December 2020

Activation of mesangial cells with TNF-alpha stimulates M-CSF gene expression and monocyte proliferation: evidence for involvement of protein kinase C and protein tyrosine kinase

1 reference

12 December 2020

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

12 December 2020

Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6)

1 reference

12 December 2020

Activation of vascular protein kinase C-beta inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance

1 reference

12 December 2020

Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.

1 reference

12 December 2020

The relationship between plasma and tissue lipids in human atherosclerosis.

1 reference

12 December 2020

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

12 December 2020

Identifiers

DOI

10.1093/CVR/CVV107

1 reference

30 June 2019

PMCID

6279179

1 reference

30 June 2019

PubMed ID

25808972

1 reference

30 June 2019